Phase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab/CD19 Depleted HSCT
Children's Hospital of Philadelphia
Children's Hospital of Philadelphia
Pierre Fabre Medicament
National Institutes of Health Clinical Center (CC)
Duke University
University of Rochester
Scripps Translational Science Institute
Roswell Park Cancer Institute
Shwachman-Diamond Syndrome Alliance Inc
Fred Hutchinson Cancer Center
CHU de Reims
Wake Forest University Health Sciences
University of California, San Francisco
Columbia University
New York Medical College
Columbia University
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)